These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 15010880)

  • 1. Comparative study of primary mammary small cell carcinoma, carcinoma with endocrine features and invasive ductal carcinoma.
    Yamamoto J; Ohshima K; Nabeshima K; Ikeda S; Iwasaki H; Kikuchi M
    Oncol Rep; 2004 Apr; 11(4):825-31. PubMed ID: 15010880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary esophageal small cell carcinoma with concomitant invasive squamous cell carcinoma or carcinoma in situ.
    Yamamoto J; Ohshima K; Ikeda S; Iwashita A; Kikuchi M
    Hum Pathol; 2003 Nov; 34(11):1108-15. PubMed ID: 14652811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
    McCluggage WG; Kennedy K; Busam KJ
    Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing medullary carcinoma of the breast from high-grade hormone receptor-negative invasive ductal carcinoma: an immunohistochemical approach.
    Flucke U; Flucke MT; Hoy L; Breuer E; Goebbels R; Rhiem K; Schmutzler R; Winzenried H; Braun M; Steiner S; Buettner R; Gevensleben H
    Histopathology; 2010 Jun; 56(7):852-9. PubMed ID: 20636789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine carcinomas of the breast.
    Rovera F; Masciocchi P; Coglitore A; La Rosa S; Dionigi G; Marelli M; Boni L; Dionigi R
    Int J Surg; 2008; 6 Suppl 1():S113-5. PubMed ID: 19167937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
    Zhao C; Bratthauer GL; Barner R; Vang R
    Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed small cell carcinomas of the uterine cervix: prognostic impact of focal neuroendocrine differentiation but not of Ki-67 labeling index.
    Horn LC; Hentschel B; Bilek K; Richter CE; Einenkel J; Leo C
    Ann Diagn Pathol; 2006 Jun; 10(3):140-3. PubMed ID: 16730307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different panels of markers should be used to predict mammary Paget's disease associated with in situ or invasive ductal carcinoma of the breast.
    Lester T; Wang J; Bourne P; Yang Q; Fu L; Tang P
    Ann Clin Lab Sci; 2009; 39(1):17-24. PubMed ID: 19201736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent overexpression of epidermal growth factor receptor (EGFR) in mammary high grade ductal carcinomas with myoepithelial differentiation.
    Shien T; Tashiro T; Omatsu M; Masuda T; Furuta K; Sato N; Akashi-Tanaka S; Uehara M; Iwamoto E; Kinoshita T; Fukutomi T; Tsuda H; Hasegawa T
    J Clin Pathol; 2005 Dec; 58(12):1299-304. PubMed ID: 16311351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small cell neuroendocrine carcinoma of the breast: a report of three cases and review of the literature.
    Adegbola T; Connolly CE; Mortimer G
    J Clin Pathol; 2005 Jul; 58(7):775-8. PubMed ID: 15976350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
    Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B
    Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
    Steinman S; Wang J; Bourne P; Yang Q; Tang P
    Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.
    Mylonas I; Jeschke U; Shabani N; Kuhn C; Friese K; Gerber B
    Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
    Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary neuroendocrine carcinoma of the vagina with Merkel cell carcinoma phenotype.
    Coleman NM; Smith-Zagone MJ; Tanyi J; Anderson ML; Coleman RL; Dyson SW; Reed JA
    Am J Surg Pathol; 2006 Mar; 30(3):405-10. PubMed ID: 16538063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large cell and small cell neuroendocrine bladder carcinoma: immunohistochemical and outcome study in a single institution.
    Alijo Serrano F; Sánchez-Mora N; Angel Arranz J; Hernández C; Alvarez-Fernández E
    Am J Clin Pathol; 2007 Nov; 128(5):733-9. PubMed ID: 17951193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical distinction between merkel cell carcinoma and small cell carcinoma of the lung.
    Bobos M; Hytiroglou P; Kostopoulos I; Karkavelas G; Papadimitriou CS
    Am J Dermatopathol; 2006 Apr; 28(2):99-104. PubMed ID: 16625069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases.
    Jones TD; Kernek KM; Yang XJ; Lopez-Beltran A; MacLennan GT; Eble JN; Lin H; Pan CX; Tretiakova M; Baldridge LA; Cheng L
    Hum Pathol; 2005 Jul; 36(7):718-23. PubMed ID: 16084939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges.
    Tang F; Wei B; Tian Z; Gilcrease MZ; Huo L; Albarracin CT; Resetkova E; Zhang H; Sahin A; Chen J; Bu H; Abraham S; Wu Y
    Histopathology; 2011 Jul; 59(1):106-15. PubMed ID: 21668471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 overexpression is a predictor of local recurrence after treatment for both in situ and invasive ductal carcinoma of the breast.
    de Roos MA; de Bock GH; de Vries J; van der Vegt B; Wesseling J
    J Surg Res; 2007 Jun; 140(1):109-14. PubMed ID: 17291532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.